#UAE #Healthcare - Abu Dhabi’s global health company M42 is adopting Oracle Health Data Intelligence to unify clinical, genomic and real-world patient data across its network. The tool will integrate with Oracle Health Foundation EHR to support chronic disease management, population health programmes and precision care. M42 will roll the platform out first within its diabetes programmes, aiming to enable earlier detection of health trends and more personalised treatment. The move builds on a longitudinal patient record initiative the two companies launched last year, which folded Emirati Genome Programme data into electronic health records.
SO WHAT? - Healthcare AI lives or dies on data quality, but most hospital networks still keep clinical, genomic and real-world data in separate systems that don’t talk to each other. M42 is trying to close that gap by pulling everything into one platform. Unifying the data could enable AI models to both spot disease patterns across a population, and to support more personalised, data-driven treatment pathways. The two companies have agreed to begin with diabetes, a chronic condition that benefits heavily from continuous monitoring and early intervention.
KEY POINTS:
M42 is to adopt Oracle Health Data Intelligence to unify clinical, genomic and real-world data across its healthcare network. The platform will be integrated with Oracle Health Foundation EHR.
The Oracle platform is designed to support chronic disease management, population health programmes and precision care delivery via AI-driven insights.
To begin with, M42 plans to deploy the platform first within its diabetes programme. The move will enable proactive patient engagement and better long-term outcomes for chronic disease patients.
The collaboration builds on a strategic partnership launched last year between M42 and Oracle that created unified longitudinal patient records across the UAE healthcare ecosystem.
That earlier data transformation initiative integrated data from the Emirati Genome Programme into electronic health records. This made pharmacogenomic information available to clinicians for the first time, allowing them to create personalised treatment pathways.
The platform is intended to give researchers advanced analytics and AI-driven exploration across large datasets. The new tools will help clinicians identify disease patterns, correlations and risk factors more efficiently.
The initiative is underpinned by data, digital and AI governance principles to ensure data is managed securely and in line with regulatory compliance.
M42, established in 2023 from the merger of G42 Healthcare and Mubadala Health, operates more than 480 facilities in 26 countries with over 20,000 employees.
ZOOM OUT - M42 emerged in April 2023, after Abu Dhabi AI group G42 and sovereign investor Mubadala Investment Company completed the merger of their healthcare arms, G42 Healthcare and Mubadala Health. The combined entity paired G42's data and AI technology with Mubadala Health's hospital network and patient services. M42 launched with assets including HealthPoint Hospital, Moorfields Eye Hospital Abu Dhabi, Imperial College London Diabetes Centre and the National Reference Laboratory. The healthcare group icontinues to expand internationally and partner with global pharmaceutical and healthtech companies.
[Written and edited with the assistance of AI]
Source: Oracle, M42
Read more about M42:
Abu Dhabi launches global digital health Innovation Hub (Middle East AI News)
M42 releases MEDIC leaderboard for clinical LLMs (Middle East AI News)
M42 delivers framework for evaluating clinical LLMs (Middle East AI News)
M42 releases new versions of clinical LLM (Middle East AI News)